Prognostic impact of PD-1 and PD-L1 expression in malignant pleural mesothelioma: an international multicenter study

BACKGROUND: Programmed cell death 1/programmed death ligand 1 (PD-1/PD-L1) immune-checkpoint blockade is a promising new therapeutic strategy in cancer. However, expression patterns and prognostic significance of PD-L1 and PD-1 are still controversial in human malignant pleural mesothelioma (MPM). M...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Transl Lung Cancer Res
Autors principals: Brcic, Luka, Klikovits, Thomas, Megyesfalvi, Zsolt, Mosleh, Berta, Sinn, Katharina, Hritcu, Richard, Laszlo, Viktoria, Cufer, Tanja, Rozman, Ales, Kern, Izidor, Mohorcic, Katja, Jakopovic, Marko, Samarzija, Miroslav, Seiwerth, Sven, Kolek, Vitezslav, Fischer, Ondřej, Jakubec, Petr, Škarda, Jozef, Gieszer, Balazs, Hegedus, Balazs, Fillinger, Janos, Renyi-Vamos, Ferenc, Buder, Anna, Bilecz, Agnes, Berger, Walter, Grusch, Michael, Hoetzenecker, Konrad, Klepetko, Walter, Hoda, Mir Alireza, Filipits, Martin, Dome, Balazs
Format: Artigo
Idioma:Inglês
Publicat: AME Publishing Company 2021
Matèries:
Original Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC8107750/
https://ncbi.nlm.nih.gov/pubmed/34012777
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/tlcr-20-1114
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars